Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00510315 · ClinicalTrials.gov registry record

Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
11
Enrollment target

NCT00510315: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00510315 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00510315 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
11 participants
Enrollment target

Study Summary

The purpose of this study is to better understand why some women who survived cancer or a related illness later develop diabetes, problems with their cholesterol, or other problems that may lead to heart disease. Because these problems may be related to treatment with total body irradiation and a stem cell transplant, the investigators will compare the rates of obesity, cholesterol problems, and diabetes between women who were treated with total body irradiation and a stem cell transplant and women who were not. The amount and location of fat stores in the abdomen is more important than overall weight or total body fat in the development of diabetes and cholesterol problems. In general, fat can be stored in several areas in the abdomen: around the organs (visceral fat), under the skin (subcutaneous fat), and in the liver (liver fat). People with higher amounts of fat around the organs (visceral fat), even those with a normal weight, are more likely to become diabetic or have high cholesterol. The amount of fat in each of these areas can be measured with an abdominal magnetic resonance imaging (MRI). In this study, the investigators will use blood tests, height, weight, waist circumference, blood pressure measurements, and an abdominal MRI to evaluate for several risk factors of heart disease, including cholesterol problems, diabetes and pre-diabetes, elevated blood pressure, and increased abdominal fat.

Interventions

  • OTHER Questionnaires, Laboratory tests, Abdominal MRI

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2007-07
Est. Completion 2016-01
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT00510315 record still lists

NCT00510315 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Questionnaires, Laboratory tests, Abdominal MRI is the first listed.

NCT00510315 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00510315 about?

NCT00510315 is a clinical study titled "Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant". The purpose of this study is to better understand why some women who survived cancer or a related illness later develop diabetes, problems with their cholesterol, or other problems that may lead to heart disease. Because these problems may be related to treatment with total body irradiation and a st...

What is the current status of trial NCT00510315?

This trial is currently completed. The enrollment target is 11 participants. The study started on 2007-07. Estimated completion is 2016-01.

What interventions are being tested in trial NCT00510315?

The interventions under investigation include: Questionnaires, Laboratory tests, Abdominal MRI (OTHER).

Who is sponsoring clinical trial NCT00510315?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00510315, the US trial registry maintained by the National Library of Medicine. NCT00510315 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.